GP

Grish Pal Singh

Active Director Director DIN 05112613
DIN 05112613 First appointment Jun 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since Jun 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Grish Pal Singh

Data last updated:

Grish Pal Singh is a Director at Atlexo Trading Private Limited (since 2026) and Director at Zoelex Pharmaceuticals Private Limited (since 2026).

DIN 05112613
Primary Designation Director
First Appointment 15 Jun 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Atlexo Trading Private Limited U46909DC2026PTC472849
Director08 Jul 20262026Active
Director15 Jun 20262026Active

Board colleagues of Grish Pal Singh

Directorship timeline

Open interactive timeline →
Zoelex Pharmaceuticals Private Limited
Atlexo Trading Private Limited
Premium access

Shareholding and investment profile for Grish Pal Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Grish Pal Singh

Grish Pal Singh currently holds 2 directorships: Atlexo Trading Private Limited (Director, since 08 Jul 2026); Zoelex Pharmaceuticals Private Limited (Director, since 15 Jun 2026).

Grish Pal Singh was first appointed on 15 Jun 2026 as Director at Zoelex Pharmaceuticals Private Limited.

The current boards of Grish Pal Singh's companies include Kavita Sengar (Atlexo Trading Private Limited), Vidhatri Singh (Zoelex Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available